Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Preferred Shares (2016)

Historic Preferred Shares for Enanta Pharmaceuticals (ENTA) over the last 2 years, with Q2 2016 value amounting to $158000.0.

  • Enanta Pharmaceuticals' Preferred Shares changed N/A to $158000.0 in Q2 2016 from the same period last year, while for Jun 2016 it was $158000.0, marking a year-over-year change of. This contributed to the annual value of $163000.0 for FY2015, which is N/A changed from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Preferred Shares stood at $158000.0 for Q2 2016.
  • Enanta Pharmaceuticals' Preferred Shares' 5-year high stood at $163000.0 during Q3 2015, with a 5-year trough of $156000.0 in Q1 2016.